- Anesthesia & Operation Center
- Blood Transfusion Department
- Burn & Plastic Surgery Department
- Cardiac Surgery Department
- Cardiology Department
- Cardiopulmonary & Extracorporeal Life Support Department
- Child Healthcare Department
- Clinical Nutrition Department
- Dermatology Department
- Developmental Behavior Department
- E.N.T. Department
- Emergency Department
- Endocrinology Department
- Gastroenterology Department
- General ICU
- General Internal Medicine
- General Surgery Department
- Genetics & Metabolism Department
- Hematology &Oncology Department
- Infections Department
- Lab Center
- Neonatal Surgery Department
- Neonatology Department
- Nephrology Department
- Neurology Department
- Neurosurgery Department
- Nursing Department
- Oncology Surgery Department
- Ophthalmology Department
- Orthopedics Department
- Pathology Department
- Pediatric & Adolescent Gynecology
- Pharmacy Department
- Psychology Department
- Pulmonology Department
- Radiology Department
- Rehabilitation Department
- Rheumatology & Immunology Department
- Stomatology Department
- Thoracic Surgery Department
- Traditional Chinese Medicine Department
- Traumatology Department
- Ultrasound Department
- Urology Department
Heart Center is the vice group leader institution of the Cardiothoracic Surgery Group of Pediatric Surgery Branch of Chinese Medical Association and key medical discipline in Zhejiang Province. The center includes cardiac surgery, cardiovascular medicine, CICU, extracorporeal circulation/extracorporeal life support, ultrasound and anesthesiology and three extracorporeal circulation operating rooms, one cardiac catheterization operating room and one inset operating room with nearly 2,000 operations performed annually. What’s more, a network platform for treating congenital heart disease in Zhejiang Province has also been built.
Laparoscopic Center is one of the earliest institutions to carry out laparoscopic surgery in children’s hospitals in China. In 1983, the center applied endoscopy technology in pediatric surgery and actively accelerated the development and application of pediatric endoscopy technology. In 2019, more than 5600 endoscopic surgeries were performed, in which the technology of choledochal cyst, congenital megacolon, hydronephrosis, splenectomy, lobectomy and hiatal hernia repair were at the leading level in China. Since 2017, more than 200 cases of Da Vinci surgery have been operated.
Nephrology Center is the key discipline in Zhejiang Province. It’s the consultant unit of Nephrology Group of Pediatric Surgery Branch of Chinese Medical Association, vice chairman unit of Committee of nephrologists, Society of Pediatrics, Chinese Medical Doctor Association, and vice group leader unit of Pediatric Urology Group of Urology Branch of Chinese Medical Association. The center comprises kidney internal medicine, urology and blood purification center. The diagnosis and treatment of pediatric nephrotic syndrome, refractory nocturnal enuresis, gender dysplasia, urinary system malformation, hereditary kidney disease are at the leading level in China. The center also has taken the lead of many national multi-center clinical researches. The number of Da Vinci robot surgery operated was ranked as the top in China and the overall strength of nephrology center located in the first tier of children’s hospitals all around the country.
Pediatric Endocrine and Metabolic Disease Center is the unit of the secretary general of Asia Pacific Pediatric Endocrinology Society. The center diretor is the president of Chinese Society of Pediatric Endocrinology and Metabolism.The center is taking the leading position in the research and management of short stature, obesity, non-alcoholic fatty liver disease, metabolic syndrome, diabetes, and disorder of sex developm nent, etc. The center buit the earliest and largest cohort of childhood obesity in China and now is leading a number of national multi-center clinical studies. The center is pioneering in China to carry the hepatic proton magnetic resonance spectroscopy (1H MRSI) assessment of -cell function, and continues glucose monitoring (CGM) in conjunction with a continues subcutaneous insulin infusion (CSII). The center has participated in four childhood diabetes international guidelines development.
Pediatric Critical Disease Treatment Center was one of the first tier of National Key Clinical Specialty units and also the earliest center for pediatric critical care medicine. The center is made up of NICU, PICU, SICU, CICU and extracorporeal life support. In 2007, the first neonatal ECMO in China was performed by the center, keeping the record of the lowest weight in Asia. At present, 130 patients have been successfully rescued by ECMO technology, in which the survival rate was higher than that of the international ELSO report and the national average level of ECMO in children’s hospitals.
Hematology-Oncology Center is the unit of chairman of Chinese Children Cancer Group and also the key medical discipline in Zhejiang Province. As the earliest research center for comprehensive treatment of pediatric leukemia and solid tumors, the center is one of the most influential platforms in China and has been ranked as top two in China pediatric hospital list for many years. The five-year event-free survival rate of childhood acute lymphoblastic leukemia and acute myeloid leukemia was ranked the top nationwide.The endoscopic (including Da Vinci) surgical techniques were at the leading level in China.
Relying on the platforms of National Clinical Research Center for Child Health and Disease and National International Scientific and Technological Cooperation Base for Diagnosis and Treatment of Birth Defect, Birth Defect and Rare Disease Treatment Center formed the “education- screening- diagnosis- treatment- prevention- management” multidisciplinary mode to meet the needs of prevention for birth defects and rare diseases. The center is one of the earliest screening units for neonatal diseases in China. It has built the largest screening center for integrating screening, diagnosis, treatment and follow-up in the world. The center, characterized by the diagnosis and treatment of rare diseases, has established a genetic diagnosis platform and multiple MDT teams for rare genetic diseases, and built a network platform for rare childhood diseases and the largest international PWS research cohort.
Neonatal Diagnosis and Treatment Center is national key clinical specialty, key medical discipline of Zhejiang Province, the unit of the vice group leader of Neonatology Group of Pediatric Surgery Branch of Chinese Medical Association and Neonatal Surgery Group of Pediatric Surgery Branch of Chinese Medical Association. The center includes neonatal intensive care center (NICU), neonatology and neonatal surgery departments. NICU was the first project constructed by HOPE Foundation in China. It’s also one of the earliest and most standardized training bases for neonatal intensive care in China.
Endoscopy Center consists of respiratory medicine, gastroenterology, otolaryngology and anesthesiology. Over the years, the amount, difficulty and quality of diagnosis and treatment of digestive endoscopy, respiratory endoscopy, otolaryngology endoscopy were all in the domestic leading position. What’s more, the center has hosted many national endoscopy continuing medical education courses, training a large number of pediatric endoscopy medical specialists in China.
Orthopaedic Center is the key discipline of Zhejiang Province and the unit of the vice group leader of Cardiothoracic Surgery Group of Pediatric Surgery Branch of Chinese Medical Association. It is composed of thoracic surgery, orthopedics, orthopaedic and radiology department. The center is featured by applying artificial intelligence and 3D scanning technology into surgery, such as chest wall deformity, cleft lip and palate, scoliosis and dislocation of hip joint, providing personalized treatment options.